HKSE - Delayed Quote HKD
PERFECT MEDICAL (1830.HK)
2.150
0.000
(0.00%)
As of 10:29:51 AM GMT+8. Market Open.
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
1,393,339
1,393,339
1,389,261
1,349,971
1,089,768
Cost of Revenue
481,968
481,968
477,084
418,281
17,914
Gross Profit
911,371
911,371
912,177
931,690
1,071,854
Operating Expense
530,020
530,020
517,639
541,595
714,724
Operating Income
381,351
381,351
394,538
390,095
357,130
Net Non Operating Interest Income Expense
1,342
1,342
-4,608
-14,349
-7,732
Pretax Income
383,723
383,723
391,456
378,153
358,160
Tax Provision
73,324
73,324
75,818
72,908
73,526
Net Income Common Stockholders
315,800
315,800
315,638
305,245
284,634
Diluted NI Available to Com Stockholders
315,800
315,800
315,638
305,245
284,634
Basic EPS
0.26
0.25
0.25
0.25
0.24
Diluted EPS
0.26
0.25
0.25
0.25
0.24
Basic Average Shares
1,256,901.500
1,256,305
1,249,157
1,230,628
1,168,988
Diluted Average Shares
1,256,901.500
1,256,305
1,249,157
1,230,628
1,168,988
Total Operating Income as Reported
382,381
382,381
396,064
392,502
365,892
Rent Expense Supplemental
8,160
8,160
6,383
6,589
2,515
Total Expenses
1,011,988
1,011,988
994,723
959,876
732,638
Net Income from Continuing & Discontinued Operation
315,800
315,800
315,638
305,245
284,634
Normalized Income
316,177.763
316,177.763
316,126.629
307,592.337
283,882.203
Interest Income
12,566
12,566
7,915
1,748
5,412
Interest Expense
11,224
11,224
12,523
16,097
13,144
Net Interest Income
1,342
1,342
-4,608
-14,349
-7,732
EBIT
394,947
394,947
403,979
394,250
371,304
EBITDA
596,909
596,909
627,572
613,296
542,560
Reconciled Cost of Revenue
481,968
481,968
477,084
418,281
17,914
Reconciled Depreciation
201,962
201,962
223,593
219,046
171,256
Net Income from Continuing Operation Net Minority Interest
315,800
315,800
315,638
305,245
284,634
Total Unusual Items Excluding Goodwill
-467
-467
-606
-2,908
946
Total Unusual Items
-467
-467
-606
-2,908
946
Normalized EBITDA
597,376
597,376
628,178
616,204
541,614
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-89.237
-89.237
-117.371
-560.663
194.203
3/31/2021 - 2/10/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade